Search results
1 – 10 of 34Sunny Vijay Arora and Malay Krishna
The learning outcomes of this study are as follows:1. the benefits of differential pricing over uniform pricing;2. the differences between second- and third-degree price…
Abstract
Learning outcomes
The learning outcomes of this study are as follows:
1. the benefits of differential pricing over uniform pricing;
2. the differences between second- and third-degree price discrimination;
3. the rationale for charging different prices for segments having different willingness to pay; and
4. how different prices for the same product can lead to perceptions of unfairness and how companies might manage such an issue.
Case overview/synopsis
This case outlines the decisions that Adar Poonawalla, the CEO of Serum Institute of India (Serum), had to make in late April 2021 concerning its pricing for the COVID-19 (Covid) vaccine. Serum was the world’s largest manufacturer of vaccines, and its Covishield vaccine had received regulatory approval, but faced an unusual challenge and opportunity. In most countries, governments had procured Covid vaccines from manufacturers and then delivered the vaccines to consumers free of cost. But in India, there was a three-tier pricing system. While the Government of India had committed to free vaccines in government-run public hospitals, it also allowed vaccine makers to directly sell vaccines to state governments, as well as private hospitals, who were at liberty to charge consumers for the vaccines. This created an interesting pricing dilemma for Serum: as different customers had different willingness to pay, should Serum use differential pricing? Would such a tiered pricing system be considered fair? How many different price points should Serum maintain? By exploring these and related decisions that Poonawalla had to make, the case is intended to teach price discrimination.
Complexity academic level
The case is intended for graduate-level courses in marketing, pricing and economics. This case illustrates the principles of differential pricing/price discrimination. More specifically, it highlights pricing strategies motivated by second- and third-degree price discrimination in an emerging market’s health-care context. From the information in the case, the student can learn to apply the concepts of second- and third-degree price discrimination in marketing. After working through the case and assignment questions, instructors will be able to help students understand the following concepts:
Teaching objective 1: the benefits of differential pricing over uniform pricing.
Teaching objective 2: the differences between second- and third-degree price discrimination.
Teaching objective 3: the rationale for charging different prices for segments having different willingness to pay.
Teaching objective 4: how different prices for the same product can lead to perceptions of unfairness and how companies might manage such an issue.
Supplementary material
Teaching notes are available for educators only.
Subject code
CSS 8: Marketing
Details
Keywords
Last week, its partners in the ‘Quad’ grouping -- the United States, Japan and Australia -- agreed to help increase its vaccine manufacturing and exporting capacity. Each of the…
Details
DOI: 10.1108/OXAN-DB260281
ISSN: 2633-304X
Keywords
Geographic
Topical
The health ministry reports that there are fewer than 2,000 active coronavirus cases in the country, a miniscule number relative to the size of the population, but the authorities…
Details
DOI: 10.1108/OXAN-DB275376
ISSN: 2633-304X
Keywords
Geographic
Topical
Earlier this month, the Drugs Controller General of India (DCGI) approved the Oxford/AstraZeneca vaccine, marketed in India as ‘Covishield’, and a locally developed jab. The…
Details
DOI: 10.1108/OXAN-DB258713
ISSN: 2633-304X
Keywords
Geographic
Topical
Gangadhar Ch, Thirumal S., Ramesh R., Damaraju Sri Sai Satyanarayana, Asadi Srinivasulu and Kranthi Kumar K.
The present digital world’s challenging issue is COVID-19. This paper is related to the process of the COVID-19 treatment based on age, gender, symptoms and previous health…
Abstract
Purpose
The present digital world’s challenging issue is COVID-19. This paper is related to the process of the COVID-19 treatment based on age, gender, symptoms and previous health issues. This paper gives the deep discussion about the prevention, symptoms, tests and treatment process. In this research work, the discussion is about vaccine invention and the side effects of the consumed medication.
Design/methodology/approach
This paper gives a clear explanation of the types of vaccine, which are lopinavir, ritonavir, remdesivir, hydroxychloroquine, chloroquine and plasma therapy. Thereafter, the discussion is prolonged to Indian vaccine for COVID-19.
Findings
This paper examines some of the COVID-19 treatment processes and difficulties, and finally, this paper aims to summarize and give an overview of the present preclinical research and clinical trials of potential candidates for COVID-19 treatments and vaccines.
Originality/value
The required information has been taken from online databases such as PubMed, Science, Nature, PNAS and Cell. Papers included were published between December 2019 and July 2020. The current results indicate the most promising outcomes for dexamethasone as a treatment and vaccine. Further research is needed to identify safe and effective treatments and vaccines for COVID-19.
Details
Keywords
Sandeep Bhasin and Bhawna Kumar
Innovation thrives during crises. Covid-19 gives one such opportunity to the pharmaceutical industry. Product innovation gives an opportunity to beat the pandemic. However…
Abstract
Innovation thrives during crises. Covid-19 gives one such opportunity to the pharmaceutical industry. Product innovation gives an opportunity to beat the pandemic. However, process innovation using the concept of co-opetition can help the pharmaceutical industry create a win–win for the market and the industry. This chapter covers co-opetition strategies that pharmaceutical sector can follow to help the customers and marketers win this game. The chapter looks at various co-operation-based strategies including co-operation by division of markets, co-operation by sharing of distribution, co-operation through patent waivers and co-operation with complementary goods manufacturers. After the co-operation, comes competition. The chapter considers duopoly as a means to help divide the market for all to co-exist.
Details
Keywords
Vineeta Dwivedi, Malay Krishna and Sunny Vijay Arora
This case is intended to help students of business communication and public relations to trace the effects of communication by public figures and understand essential elements of…
Abstract
Learning outcomes
This case is intended to help students of business communication and public relations to trace the effects of communication by public figures and understand essential elements of designing effective communication. After working through the case and assignment questions, the students will be able to:understand the drivers of vaccine hesitancy;analyze the effects of mass communication on public sentiment, in a fast-changing public health situation; anddesign interventions to influence public awareness and action, using a simple model (5W) for mass communication.
Case overview/synopsis
As the vaccines first arrived after the devastating first wave of the Covid-19 pandemic, Indians hesitated to take the shot. Vaccine hesitancy, a worldwide phenomenon, hampered the uptake of the first Covid vaccines despite the dark clouds of the lethal disease. The case looks at the massive problem of vaccine hesitancy and how an integrated communication strategy could overcome and mitigate the challenge. The case protagonist, the leader of a communications agency, looks at the messaging, medium and platforms needed for strategic communication pitch to combat this vaccine hesitancy.
Complexity academic level
The case was designed for use in a graduate-level course in business communication. This case may be positioned toward the middle or end of the course to illustrate mass communication strategy for pressing and sensitive challenges. The case may also be used in a course on public relations, both at graduate and undergraduate levels.
Supplementary materials
Teaching notes are available for educators only.
Subject code
CSS 8: Marketing.
Details
Keywords
India suspended its ‘vaccine diplomacy’ in April, choosing to prioritise shots for its own population, as it came under pressure from a massive second wave of COVID-19 infections…
Details
DOI: 10.1108/OXAN-DB263283
ISSN: 2633-304X
Keywords
Geographic
Topical
Its vaccine production capacity has increased in the intervening period to the extent that it now has a surplus of doses, even allowing for supplies abroad. A key reason why so…
Details
DOI: 10.1108/OXAN-DB265715
ISSN: 2633-304X
Keywords
Geographic
Topical
The article aims to critically examine India's COVID-19 vaccination policy by analyzing the problem, politics and policy developed during the pandemic. The article would help the…
Abstract
Purpose
The article aims to critically examine India's COVID-19 vaccination policy by analyzing the problem, politics and policy developed during the pandemic. The article would help the policy-makers and healthcare administrators to understand the situation in a holistic manner.
Design/methodology/approach
The article employs Kingdon's multiple streams framework, which separately analyzes the problem at hand, the politics that are at work and the policy which is being developed when the problem and politics streams are activated. Directed approach to content analysis is adopted in this article.
Findings
The article provides a holistic overview of vaccine development and the vaccination policy during the COVID-19 pandemic in India.
Practical implications
The analysis would help policy-makers and healthcare administrators to have a bird's-eye view of the COVID-19 vaccine development and the vaccination drive.
Originality/value
The article is a macro-level analysis of an extremely important situation of COVID-19 vaccine development and the subsequent vaccination drive for the world's largest democracy, which is also one of the largest drugs and vaccine manufacturing countries. The article captures the bird's-eye-view of the problem of vaccine development, the policy of funding as well as procurement, and the politics of vaccine distribution in the country.
Details